Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluxunit is the corporate venture and incubation arm of OSRAM, now associated with ams OSRAM, based in Munich, Germany. Rather than being a drug developer or healthcare operating company, it invests in and supports startups with novel technologies and business models across areas such as sensors, photonics, autonomous systems, AR/VR, AI, and selected health or medtech applications. The organization functions as both an incubator and venture investor, helping create and scale businesses that can extend OSRAM’s strategic reach beyond traditional lighting. For biotech and healthcare diligence purposes, Fluxunit is best classified as a non-health corporate investor with occasional exposure to digital health and medtech opportunities, not as a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluxunit.